Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Controlled 'One-Cell-One-Bead' Encapsulation in Droplets


Technology Benefits

Modular microfluidic technology that is capable of encapsulating one cell and one bead in one droplet Increased droplet encapsulation efficiency Improved droplet throughput for sequencing applications including single cell genomics and proteomics.


Technology Application

Improving pharmacological assay throughput by efficiently generating droplets that encapsulate a single cell and beadCapture specific proteins and antigens from single cells using functionalized beads


Detailed Technology Description

Encapsulation of a single cell and bead reagent is of critical importance when conducting droplet based analysis of single cells. Currently, droplet encapsulation is not well controlled. One-cell-one-bead encapsulation efficiency is limited by an uncontrolled random droplet encapsulation of cells and beads (0.1% 1 in 100 droplets). This low droplet encapsulation efficiency hinders the realization of high throughput droplet based experiments. UCI researchers have developed a microfluidic droplet encapsulation method to efficiently encapsulate one-cell and one bead. By designing a microfluidic device with controllable fluid flow and a high force liquid-liquid interface, one-cell one-bead droplet encapsulation efficacy can be well controlled. Utilizing the invented technology, it has been shown that a significantly large increase in droplet encapsulation efficiency can now be readily achieved. Whereas existing techniques only provide random encapsulation governed by Poisson statistics, the improved encapsulation efficiency in this invention enhances the ability to perform single cell genomics and proteomics on a microfluidic platform.


Others

State Of Development

Inventors have completed the experimental and validation phase with a working prototype. As the next step, the inventors plan to optimize device parameters in hopes to commercialize or license the technology.


Tech ID/UC Case

28925/2017-814-0


Related Cases

2017-814-0


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View